IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study

发表于 1 小时前

DOI号:10.1016/S2352-3026(25)00253-4

文献链接:https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(25)00253-4/abstract

文献作者:Qianwen Xu, MS[url=]a[/url],[url=]b[/url],[url=]*[/url] ∙ Yugang Guo, PhD[url=]c[/url],[url=]d[/url],[url=]e[/url],[url=]f[/url],[url=]*[/url] ∙ Min Gao, PhD[url=]c[/url],[url=]d[/url],[url=]*[/url] ∙ Lei Xue, MS[url=]a[/url],[url=]*[/url] ∙ Hui Xu, MS[url=]a[/url] ∙ Hui Li, MS[url=]a[/url],[url=]b[/url] ∙ Xuhan Zhang, MD[url=]a[/url] ∙ Chongling Liu, MS[url=]e[/url] ∙ Youjia Li, PhD[url=]e[/url] ∙ Qian Chen, PhD[url=]e[/url] ∙ Jingjing Ren, MD[url=]e[/url] ∙ Karthik Sathiyanadan, PhD[url=]e[/url] ∙ Prof Yongxian Hu, MD[url=]f[/url],[url=]g[/url],[url=]h[/url],[url=]†[/url] ∙ Prof Li Tang, PhD[url=]i[/url],[url=]j[/url],[url=]†[/url] ∙ Prof He Huang, MD[url=]f[/url],[url=]g[/url],[url=]h[/url],[url=]†[/url] ∙ Prof Xingbing Wang, MD

备注信息:

Xu Q, Guo Y, Gao M et al.
IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study
The Lancet Haematology, 2025; 12, e898-e907

[Elsevier/Sciencedirect] IL-10-expressing, anti-CD19 CAR T cells for patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: an open-label, single-arm, phase 1 study